[2] [7] These findings led regulatory authorities, including the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA), to include specific warnings and precautions in the prescribing information for all GLP-1 medications
JAMA (2019) 321:1457
To ensure optimal FcRn binding, cellular transport, and PK properties of albumin-based biologics, we attempted to substitute the C-terminal L585 of albumin with an amino acid residue that would not be recognized by CPA
Eli Lilly is also developing oral GLP-1 receptor agonists, including compounds such as orforglipron, which have shown significant weight loss and glycemic improvements in Phase III clinical trials

Thats why we combed Reddit to find out what people are currently talking about in obesity and GLP-1 communities and asked the following medical experts to respond to readers most pressing questions: Kia Mitchell, MD Double board-certified family and obesity medicine physician and founder of the International Womens Obesity Network Marsha Novick, MD, FAAFP Spokesperson for The Obesity Society and board member of the American Board of Obesity Medicine Richele Corrado, DO, MPH Spokesperson for The Obesity Society and medical director, internist, and obesity medicine physician at Revolution Medicine, Health & Fitness Sherrie Singh-Bryan, PharmD, CDCES Clinical pharmacist and certified diabetic care and education specialist at Winn Army Community Hospital in Fort Stewart, Georgia Editors note: These interviews have been edited for length and clarity
To tackle this, make hydration a priority